Global and China Polymer Drug Conjugates Market Insights, Forecast to 2027

Global and China Polymer Drug Conjugates Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Polymer Drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Polymer Drug Conjugates Market Size Growth Rate by Type
1.2.2 Polymer-Dox Conjugates
1.2.3 Polymer-Paclitaxel Conjugates
1.2.4 Polymer-Camptothecin Conjugates
1.2.5 Polymer-Platinate Conjugates
1.3 Market by Application
1.3.1 Global Polymer Drug Conjugates Market Size Growth Rate by Application
1.3.2 Cancer Treatment
1.3.3 Leukmia
1.3.4 Hepatitis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polymer Drug Conjugates Market Size, Estimates and Forecasts
2.1.1 Global Polymer Drug Conjugates Revenue 2016-2027
2.1.2 Global Polymer Drug Conjugates Sales 2016-2027
2.2 Global Polymer Drug Conjugates, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Polymer Drug Conjugates Historical Market Size by Region (2016-2021)
2.3.1 Global Polymer Drug Conjugates Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Polymer Drug Conjugates Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Polymer Drug Conjugates Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Polymer Drug Conjugates Sales Forecast by Region (2022-2027)
2.4.2 Global Polymer Drug Conjugates Revenue Forecast by Region (2022-2027)
3 Global Polymer Drug Conjugates Competitor Landscape by Players
3.1 Global Top Polymer Drug Conjugates Manufacturers by Sales
3.1.1 Global Polymer Drug Conjugates Sales by Manufacturer (2016-2021)
3.1.2 Global Polymer Drug Conjugates Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Polymer Drug Conjugates Manufacturers by Revenue
3.2.1 Key Polymer Drug Conjugates Manufacturers Covered: Ranking by Revenue
3.2.2 Global Polymer Drug Conjugates Revenue by Manufacturers (2016-2021)
3.2.3 Global Polymer Drug Conjugates Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Polymer Drug Conjugates Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Polymer Drug Conjugates Revenue in 2020
3.2.6 Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Polymer Drug Conjugates Price by Manufacturers
3.4 Global Polymer Drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Polymer Drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polymer Drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Polymer Drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Polymer Drug Conjugates Market Size by Type (2016-2021)
4.1.1 Global Polymer Drug Conjugates Sales by Type (2016-2021)
4.1.2 Global Polymer Drug Conjugates Revenue by Type (2016-2021)
4.1.3 Polymer Drug Conjugates Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Polymer Drug Conjugates Market Size Forecast by Type (2022-2027)
4.2.1 Global Polymer Drug Conjugates Sales Forecast by Type (2022-2027)
4.2.2 Global Polymer Drug Conjugates Revenue Forecast by Type (2022-2027)
4.2.3 Polymer Drug Conjugates Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Polymer Drug Conjugates Market Size by Application (2016-2021)
5.1.1 Global Polymer Drug Conjugates Sales by Application (2016-2021)
5.1.2 Global Polymer Drug Conjugates Revenue by Application (2016-2021)
5.1.3 Polymer Drug Conjugates Price by Application (2016-2021)
5.2 Polymer Drug Conjugates Market Size Forecast by Application (2022-2027)
5.2.1 Global Polymer Drug Conjugates Sales Forecast by Application (2022-2027)
5.2.2 Global Polymer Drug Conjugates Revenue Forecast by Application (2022-2027)
5.2.3 Global Polymer Drug Conjugates Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Polymer Drug Conjugates Market Size YoY Growth 2016-2027
6.1.1 China Polymer Drug Conjugates Sales YoY Growth 2016-2027
6.1.2 China Polymer Drug Conjugates Revenue YoY Growth 2016-2027
6.1.3 China Polymer Drug Conjugates Market Share in Global Market 2016-2027
6.2 China Polymer Drug Conjugates Market Size by Players (International and Local Players)
6.2.1 China Top Polymer Drug Conjugates Players by Sales (2016-2021)
6.2.2 China Top Polymer Drug Conjugates Players by Revenue (2016-2021)
6.3 China Polymer Drug Conjugates Historic Market Review by Type (2016-2021)
6.3.1 China Polymer Drug Conjugates Sales Market Share by Type (2016-2021)
6.3.2 China Polymer Drug Conjugates Revenue Market Share by Type (2016-2021)
6.3.3 China Polymer Drug Conjugates Price by Type (2016-2021)
6.4 China Polymer Drug Conjugates Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Polymer Drug Conjugates Sales Forecast by Type (2022-2027)
6.4.2 China Polymer Drug Conjugates Revenue Forecast by Type (2022-2027)
6.4.3 China Polymer Drug Conjugates Price Forecast by Type (2022-2027)
6.5 China Polymer Drug Conjugates Historic Market Review by Application (2016-2021)
6.5.1 China Polymer Drug Conjugates Sales Market Share by Application (2016-2021)
6.5.2 China Polymer Drug Conjugates Revenue Market Share by Application (2016-2021)
6.5.3 China Polymer Drug Conjugates Price by Application (2016-2021)
6.6 China Polymer Drug Conjugates Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Polymer Drug Conjugates Sales Forecast by Application (2022-2027)
6.6.2 China Polymer Drug Conjugates Revenue Forecast by Application (2022-2027)
6.6.3 China Polymer Drug Conjugates Price Forecast by Application (2022-2027)
7 North America
7.1 North America Polymer Drug Conjugates Market Size YoY Growth 2016-2027
7.2 North America Polymer Drug Conjugates Market Facts & Figures by Country
7.2.1 North America Polymer Drug Conjugates Sales by Country (2016-2021)
7.2.2 North America Polymer Drug Conjugates Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Polymer Drug Conjugates Market Size YoY Growth 2016-2027
8.2 Asia Pacific Polymer Drug Conjugates Market Facts & Figures by Region
8.2.1 Asia Pacific Polymer Drug Conjugates Sales by Region (2016-2021)
8.2.2 Asia Pacific Polymer Drug Conjugates Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Polymer Drug Conjugates Market Size YoY Growth 2016-2027
9.2 Europe Polymer Drug Conjugates Market Facts & Figures by Country
9.2.1 Europe Polymer Drug Conjugates Sales by Country (2016-2021)
9.2.2 Europe Polymer Drug Conjugates Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Polymer Drug Conjugates Market Size YoY Growth 2016-2027
10.2 Latin America Polymer Drug Conjugates Market Facts & Figures by Country
10.2.1 Latin America Polymer Drug Conjugates Sales by Country (2016-2021)
10.2.2 Latin America Polymer Drug Conjugates Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Polymer Drug Conjugates Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Polymer Drug Conjugates Market Facts & Figures by Country
11.2.1 Middle East and Africa Polymer Drug Conjugates Sales by Country (2016-2021)
11.2.2 Middle East and Africa Polymer Drug Conjugates Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 3S Bio
12.1.1 3S Bio Corporation Information
12.1.2 3S Bio Description and Business Overview
12.1.3 3S Bio Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.1.4 3S Bio Polymer Drug Conjugates Products Offered
12.1.5 3S Bio Recent Development
12.2 Abeona Therapeutics
12.2.1 Abeona Therapeutics Corporation Information
12.2.2 Abeona Therapeutics Description and Business Overview
12.2.3 Abeona Therapeutics Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abeona Therapeutics Polymer Drug Conjugates Products Offered
12.2.5 Abeona Therapeutics Recent Development
12.3 Abramson Cancer Center
12.3.1 Abramson Cancer Center Corporation Information
12.3.2 Abramson Cancer Center Description and Business Overview
12.3.3 Abramson Cancer Center Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abramson Cancer Center Polymer Drug Conjugates Products Offered
12.3.5 Abramson Cancer Center Recent Development
12.4 Access Pharmaceuticals
12.4.1 Access Pharmaceuticals Corporation Information
12.4.2 Access Pharmaceuticals Description and Business Overview
12.4.3 Access Pharmaceuticals Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Access Pharmaceuticals Polymer Drug Conjugates Products Offered
12.4.5 Access Pharmaceuticals Recent Development
12.5 Adama
12.5.1 Adama Corporation Information
12.5.2 Adama Description and Business Overview
12.5.3 Adama Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Adama Polymer Drug Conjugates Products Offered
12.5.5 Adama Recent Development
12.6 Eyetech
12.6.1 Eyetech Corporation Information
12.6.2 Eyetech Description and Business Overview
12.6.3 Eyetech Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eyetech Polymer Drug Conjugates Products Offered
12.6.5 Eyetech Recent Development
12.7 Ferring
12.7.1 Ferring Corporation Information
12.7.2 Ferring Description and Business Overview
12.7.3 Ferring Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ferring Polymer Drug Conjugates Products Offered
12.7.5 Ferring Recent Development
12.8 Flamel Technologies
12.8.1 Flamel Technologies Corporation Information
12.8.2 Flamel Technologies Description and Business Overview
12.8.3 Flamel Technologies Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Flamel Technologies Polymer Drug Conjugates Products Offered
12.8.5 Flamel Technologies Recent Development
12.9 Genentech
12.9.1 Genentech Corporation Information
12.9.2 Genentech Description and Business Overview
12.9.3 Genentech Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Genentech Polymer Drug Conjugates Products Offered
12.9.5 Genentech Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Corporation Information
12.10.2 GlaxoSmithKline Description and Business Overview
12.10.3 GlaxoSmithKline Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GlaxoSmithKline Polymer Drug Conjugates Products Offered
12.10.5 GlaxoSmithKline Recent Development
12.11 3S Bio
12.11.1 3S Bio Corporation Information
12.11.2 3S Bio Description and Business Overview
12.11.3 3S Bio Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.11.4 3S Bio Polymer Drug Conjugates Products Offered
12.11.5 3S Bio Recent Development
12.12 Gynecologic Oncology Group Foundation
12.12.1 Gynecologic Oncology Group Foundation Corporation Information
12.12.2 Gynecologic Oncology Group Foundation Description and Business Overview
12.12.3 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Gynecologic Oncology Group Foundation Products Offered
12.12.5 Gynecologic Oncology Group Foundation Recent Development
12.13 JenKem Technology
12.13.1 JenKem Technology Corporation Information
12.13.2 JenKem Technology Description and Business Overview
12.13.3 JenKem Technology Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.13.4 JenKem Technology Products Offered
12.13.5 JenKem Technology Recent Development
12.14 Landec
12.14.1 Landec Corporation Information
12.14.2 Landec Description and Business Overview
12.14.3 Landec Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Landec Products Offered
12.14.5 Landec Recent Development
12.15 Lipotek
12.15.1 Lipotek Corporation Information
12.15.2 Lipotek Description and Business Overview
12.15.3 Lipotek Polymer Drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Lipotek Products Offered
12.15.5 Lipotek Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Polymer Drug Conjugates Industry Trends
13.2 Polymer Drug Conjugates Market Drivers
13.3 Polymer Drug Conjugates Market Challenges
13.4 Polymer Drug Conjugates Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polymer Drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Polymer Drug Conjugates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Polymer-Dox Conjugates
Table 3. Major Manufacturers of Polymer-Paclitaxel Conjugates
Table 4. Major Manufacturers of Polymer-Camptothecin Conjugates
Table 5. Major Manufacturers of Polymer-Platinate Conjugates
Table 6. Global Polymer Drug Conjugates Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 7. Global Polymer Drug Conjugates Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Polymer Drug Conjugates Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Polymer Drug Conjugates Sales Market Share by Regions (2016-2021)
Table 10. Global Polymer Drug Conjugates Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Polymer Drug Conjugates Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Polymer Drug Conjugates Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Polymer Drug Conjugates Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Polymer Drug Conjugates Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Polymer Drug Conjugates Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Polymer Drug Conjugates Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Polymer Drug Conjugates Manufacturers by Revenue (US$ Million) in 2020
Table 18. Polymer Drug Conjugates Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Polymer Drug Conjugates Revenue Share by Manufacturers (2016-2021)
Table 20. Global Polymer Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Polymer Drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymer Drug Conjugates as of 2020)
Table 22. Key Manufacturers Polymer Drug Conjugates Price (2016-2021) (USD/Pcs)
Table 23. Polymer Drug Conjugates Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Polymer Drug Conjugates Product Type
Table 25. Date of International Manufacturers Enter into Polymer Drug Conjugates Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Polymer Drug Conjugates Sales by Type (2016-2021) (K Pcs)
Table 28. Global Polymer Drug Conjugates Sales Share by Type (2016-2021)
Table 29. Global Polymer Drug Conjugates Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Polymer Drug Conjugates Revenue Share by Type (2016-2021)
Table 31. Polymer Drug Conjugates Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Polymer Drug Conjugates Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Polymer Drug Conjugates Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Polymer Drug Conjugates Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Polymer Drug Conjugates Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Polymer Drug Conjugates Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Polymer Drug Conjugates Sales by Application (2016-2021) (K Pcs)
Table 38. Global Polymer Drug Conjugates Sales Share by Application (2016-2021)
Table 39. Global Polymer Drug Conjugates Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Polymer Drug Conjugates Revenue Share by Application (2016-2021)
Table 41. Polymer Drug Conjugates Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 42. Global Polymer Drug Conjugates Sales Forecast by Application (2022-2027) & (K Pcs)
Table 43. Global Polymer Drug Conjugates Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Polymer Drug Conjugates Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Polymer Drug Conjugates Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Polymer Drug Conjugates Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 47. China Polymer Drug Conjugates Sales (K Pcs) of Key Companies (2016-2021)
Table 48. China Polymer Drug Conjugates Sales Share by Company (2016-2021)
Table 49. China Polymer Drug Conjugates Revenue (US$ Million) by Company (2016-2021)
Table 50. China Polymer Drug Conjugates Revenue Share by Company (2016-2021)
Table 51. China Polymer Drug Conjugates Sales (K Pcs) by Type (2016-2021)
Table 52. China Polymer Drug Conjugates Sales Share by Type (2016-2021)
Table 53. China Polymer Drug Conjugates Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Polymer Drug Conjugates Price (USD/Pcs) by Type (2016-2021)
Table 55. China Polymer Drug Conjugates Sales (K Pcs) by Type (2022-2027)
Table 56. China Polymer Drug Conjugates Sales Share by Type (2022-2027)
Table 57. China Polymer Drug Conjugates Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Polymer Drug Conjugates Revenue Share by Type (2022-2027)
Table 59. China Polymer Drug Conjugates Price (USD/Pcs) by Type (2022-2027)
Table 60. China Polymer Drug Conjugates Sales (K Pcs) by Application (2016-2021)
Table 61. China Polymer Drug Conjugates Sales Share by Application (2016-2021)
Table 62. China Polymer Drug Conjugates Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Polymer Drug Conjugates Price (USD/Pcs) by Application (2016-2021)
Table 64. China Polymer Drug Conjugates Sales (K Pcs) by Application (2022-2027)
Table 65. China Polymer Drug Conjugates Sales Share by Application (2022-2027)
Table 66. China Polymer Drug Conjugates Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Polymer Drug Conjugates Revenue Share by Application (2022-2027)
Table 68. China Polymer Drug Conjugates Price (USD/Pcs) by Application (2022-2027)
Table 69. North America Polymer Drug Conjugates Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Polymer Drug Conjugates Sales Market Share by Country (2016-2021)
Table 71. North America Polymer Drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Polymer Drug Conjugates Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Polymer Drug Conjugates Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Polymer Drug Conjugates Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Polymer Drug Conjugates Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Polymer Drug Conjugates Revenue Market Share by Region (2016-2021)
Table 77. Europe Polymer Drug Conjugates Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Polymer Drug Conjugates Sales Market Share by Country (2016-2021)
Table 79. Europe Polymer Drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Polymer Drug Conjugates Revenue Market Share by Country (2016-2021)
Table 81. Latin America Polymer Drug Conjugates Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Polymer Drug Conjugates Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Polymer Drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Polymer Drug Conjugates Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Polymer Drug Conjugates Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Polymer Drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Polymer Drug Conjugates Revenue Market Share by Country (2016-2021)
Table 89. 3S Bio Corporation Information
Table 90. 3S Bio Description and Business Overview
Table 91. 3S Bio Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. 3S Bio Polymer Drug Conjugates Product
Table 93. 3S Bio Recent Development
Table 94. Abeona Therapeutics Corporation Information
Table 95. Abeona Therapeutics Description and Business Overview
Table 96. Abeona Therapeutics Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. Abeona Therapeutics Product
Table 98. Abeona Therapeutics Recent Development
Table 99. Abramson Cancer Center Corporation Information
Table 100. Abramson Cancer Center Description and Business Overview
Table 101. Abramson Cancer Center Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Abramson Cancer Center Product
Table 103. Abramson Cancer Center Recent Development
Table 104. Access Pharmaceuticals Corporation Information
Table 105. Access Pharmaceuticals Description and Business Overview
Table 106. Access Pharmaceuticals Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Access Pharmaceuticals Product
Table 108. Access Pharmaceuticals Recent Development
Table 109. Adama Corporation Information
Table 110. Adama Description and Business Overview
Table 111. Adama Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. Adama Product
Table 113. Adama Recent Development
Table 114. Eyetech Corporation Information
Table 115. Eyetech Description and Business Overview
Table 116. Eyetech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Eyetech Product
Table 118. Eyetech Recent Development
Table 119. Ferring Corporation Information
Table 120. Ferring Description and Business Overview
Table 121. Ferring Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. Ferring Product
Table 123. Ferring Recent Development
Table 124. Flamel Technologies Corporation Information
Table 125. Flamel Technologies Description and Business Overview
Table 126. Flamel Technologies Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. Flamel Technologies Product
Table 128. Flamel Technologies Recent Development
Table 129. Genentech Corporation Information
Table 130. Genentech Description and Business Overview
Table 131. Genentech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Genentech Product
Table 133. Genentech Recent Development
Table 134. GlaxoSmithKline Corporation Information
Table 135. GlaxoSmithKline Description and Business Overview
Table 136. GlaxoSmithKline Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 137. GlaxoSmithKline Product
Table 138. GlaxoSmithKline Recent Development
Table 139. Gowan Corporation Information
Table 140. Gowan Description and Business Overview
Table 141. Gowan Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 142. Gowan Product
Table 143. Gowan Recent Development
Table 144. Gynecologic Oncology Group Foundation Corporation Information
Table 145. Gynecologic Oncology Group Foundation Description and Business Overview
Table 146. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Gynecologic Oncology Group Foundation Product
Table 148. Gynecologic Oncology Group Foundation Recent Development
Table 149. JenKem Technology Corporation Information
Table 150. JenKem Technology Description and Business Overview
Table 151. JenKem Technology Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. JenKem Technology Product
Table 153. JenKem Technology Recent Development
Table 154. Landec Corporation Information
Table 155. Landec Description and Business Overview
Table 156. Landec Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 157. Landec Product
Table 158. Landec Recent Development
Table 159. Lipotek Corporation Information
Table 160. Lipotek Description and Business Overview
Table 161. Lipotek Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 162. Lipotek Product
Table 163. Lipotek Recent Development
Table 164. Polymer Drug Conjugates Market Trends
Table 165. Polymer Drug Conjugates Market Drivers
Table 166. Polymer Drug Conjugates Market Challenges
Table 167. Polymer Drug Conjugates Market Restraints
Table 168. Polymer Drug Conjugates Customers List
Table 169. Polymer Drug Conjugates Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Polymer Drug Conjugates Product Picture
Figure 2. Global Polymer Drug Conjugates Sales Market Share by Type in 2020 & 2027
Figure 3. Polymer-Dox Conjugates Product Picture
Figure 4. Polymer-Paclitaxel Conjugates Product Picture
Figure 5. Polymer-Camptothecin Conjugates Product Picture
Figure 6. Polymer-Platinate Conjugates Product Picture
Figure 7. Global Polymer Drug Conjugates Sales Market Share by Application in 2020 & 2027
Figure 8. Cancer Treatment
Figure 9. Leukmia
Figure 10. Hepatitis
Figure 11. Others
Figure 12. Polymer Drug Conjugates Report Years Considered
Figure 13. Global Polymer Drug Conjugates Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Polymer Drug Conjugates Market Size 2016-2027 (US$ Million)
Figure 15. Global Polymer Drug Conjugates Sales 2016-2027 (K Pcs)
Figure 16. Global Polymer Drug Conjugates Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Polymer Drug Conjugates Sales Market Share by Region (2016-2021)
Figure 18. Global Polymer Drug Conjugates Sales Market Share by Region in 2020
Figure 19. Global Polymer Drug Conjugates Revenue Market Share by Region (2016-2021)
Figure 20. Global Polymer Drug Conjugates Revenue Market Share by Region in 2020
Figure 21. Global Polymer Drug Conjugates Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Polymer Drug Conjugates Revenue in 2020
Figure 23. Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Polymer Drug Conjugates Sales Market Share by Type (2016-2021)
Figure 25. Global Polymer Drug Conjugates Sales Market Share by Type in 2020
Figure 26. Global Polymer Drug Conjugates Revenue Market Share by Type (2016-2021)
Figure 27. Global Polymer Drug Conjugates Revenue Market Share by Type in 2020
Figure 28. Global Polymer Drug Conjugates Sales Market Share by Application (2016-2021)
Figure 29. Global Polymer Drug Conjugates Sales Market Share by Application in 2020
Figure 30. Global Polymer Drug Conjugates Revenue Market Share by Application (2016-2021)
Figure 31. Global Polymer Drug Conjugates Revenue Market Share by Application in 2020
Figure 32. China Polymer Drug Conjugates Sales Growth Rate 2016-2027 (K Pcs)
Figure 33. China Polymer Drug Conjugates Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Polymer Drug Conjugates Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Polymer Drug Conjugates Players Market Share by Revenue in Polymer Drug Conjugates in 2020
Figure 36. China Polymer Drug Conjugates Revenue Share by Type (2016-2021)
Figure 37. China Polymer Drug Conjugates Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Polymer Drug Conjugates Revenue Share by Application (2016-2021)
Figure 39. China Polymer Drug Conjugates Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Polymer Drug Conjugates Sales Growth Rate 2016-2021 (K Pcs)
Figure 41. North America Polymer Drug Conjugates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Polymer Drug Conjugates Sales Market Share by Country in 2020
Figure 43. North America Polymer Drug Conjugates Revenue Market Share by Country in 2020
Figure 44. U.S. Polymer Drug Conjugates Sales Growth Rate (2016-2021) (K Pcs)
Figure 45. U.S. Polymer Drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Polymer Drug Conjugates Sales Growth Rate (2016-2021) (K Pcs)
Figure 47. Canada Polymer Drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Polymer Drug Conjugates Sales Growth Rate 2016-2021 (K Pcs)
Figure 49. Europe Polymer Drug Conjugates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Polymer Drug Conjugates Sales Market Share by Country in 2020
Figure 51. Europe Polymer Drug Conjugates Revenue Market Share by Country in 2020
Figure 52. Germany Polymer Drug Conjugates Sales Growth Rate (2016-2021) (K Pcs)
Figure 53. Germany Poly

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs